Pfizer is submitting its application to the FDA for emergency use of its Covid-19 vaccine. If approved, administration of the vaccine could begin before the end of the year. The FDA has approved emergency use of Eli Lilly’s arthritis drug baricitinib in combination with Gilead’s remdesivir to treat Covid-19 patients. Eli Lilly CEO David Ricks and CNBC’s Meg Tirrell discuss distribution, supply, and the path to approval for coronavirus treatments. Plus, IMAX CEO Richard Gelfond is planning ahead ...
Nov 20, 2020•24 min
David Boies, the lawyer who counseled former Vice President Al Gore in the 2000 election Florida recount, says President Trump will be unable to overturn the 2020 election results. Covid-19 cases are rising with hopes for an effective vaccine. In light of positive news from Pfizer, Moderna, and AstraZeneca, former Aetna CEO Mark Bertolini considers the current plans for managing supply and distribution and offers his own method as an alternative. SEC Chairman Jay Clayton is leaving his post afte...
Nov 19, 2020•37 min
As Covid cases rise and states impose new curfews to stem the spread, Pfizer & BioNtech have unveiled their coronavirus vaccine’s final data analysis. Their vaccine proved 95% effective in preventing the coronavirus, higher than preliminary data originally revealed. Former FDA Commissioner and Pfizer board member Dr. Scott Gottlieb discusses the bumpy but significantly shorter road to the end of the pandemic. He addresses next steps for lawmakers, Moderna, and Pfizer as they strategize vacci...
Nov 18, 2020•32 min
The S&P 500 will finally add Tesla to its index in mid-December. Elon Musk’s electric vehicle company now tops $400B in market cap. Warren Buffett’s Berkshire Hathaway made some changes to its equity portfolio in the last quarter, trimming its stakes in Apple and JPMorgan and betting on drug stocks and T-Mobile. Amazon is jumping into the pharmacy business with online prescription fulfillment and delivery for Prime members. Plus, conservative Americans may be seeking new media platforms; New...
Nov 17, 2020•28 min
In Moderna’s ongoing clinical trial, the drugmaker’s Covid vaccine proved 94.5% effective in preventing the coronavirus. In an exclusive interview, CEO Stephane Bancel and CNBC’s Meg Tirrell discuss the news, the bright light at the end of the pandemic tunnel, and ensuring a steady supply of vaccines to those who need it most. Plus, former Citigroup chairman and former Time Warner CEO Richard Parsons considers what the vaccine would mean for American business, what a contested election would mea...
Nov 16, 2020•40 min
Social media entrepreneur and venture capitalist Alexis Ohanian urges Americans to consider the role social platforms should play in society. He examines where the Internet started, where it’s going, and how the “levers of power should be wielded.” He and Aylon Steinhart, founder of plant-based ice cream company Eclipse, outline a positive outlook for the startups and entrepreneurs who’ll emerge from the collective trauma and chaos of 2020. Restaurateur Cameron Mitchell operates over 30 establis...
Nov 13, 2020•39 min
Parler, a new social media platform that touts itself as a less censored alternative to Facebook and Twitter, is rising in popularity, particularly among conservative Americans. The Anti-Defamation League’s Jonathan Greenblatt says Parler’s free speech mission might be leaving too wide an opening for harmful content. Morgan Stanley’s Mike Wilson says this bull market has a long way to run, both in timing and pricing; he offers investors some cautionary advice. Plus, former FDA Commissioner Dr. S...
Nov 12, 2020•41 min
In a rare interview, Lyft co-founder and President John Zimmer discusses the ridesharing app’s path to profitability, plans for food delivery (or not), and a post-pandemic boost to business. Plus, the U.S. is celebrating and remembering veterans today; former CIA Director and retired U.S. Army general David Petraeus explains why it’s a good day to thank our servicemen and servicewomen, and an even better time to hire them. General Petraeus examines President-Elect Joe Biden’s campaign promise to...
Nov 12, 2020•25 min
In the wake of Pfizer’s positive vaccine news, markets are rallying on hopes of a light at the end of the pandemic tunnel. BET and RLJ Companies founder Bob Johnson is relieved by the news but looking ahead; he discusses the pandemic’s disproportionate impact on Black Americans, and shares his vision for narrowing the racial health and wealth gap under a new administration. Plus, Target has entered a deal with Ulta Beauty, Amazon is in hot water in the EU, and Tesla is making up for defective co...
Nov 10, 2020•29 min
Ed Clissold, market strategist for Ned Davis Research Group, puts this week’s election in perspective with market and election data going back to 1900. Historically, a Republican incumbent victory prompts a market rally in the short term, but a reversal in the year following. Essayist and “Black Swan” investor Nassim Nicholas Taleb outlined the risks of a pandemic earlier in 2020, and now says the solution is simple, if only governments around the world could move past their coronavirus denial. ...
Nov 09, 2020•35 min
In what Pfizer CEO Albert Bourla calls “likely the most significant medical advancement in the last 100 years,” BioNtech and Pfizer’s Covid-19 vaccine may prove to be more than 90% effective in preventing coronavirus. CNBC’s Senior Health and Science Reporter Meg Tirrell breaks the good news with the Squawk Box anchors, and Pfizer CEO Dr. Albert Bourla discusses the success, the implications, and the questions still unanswered. In an extended interview, Bourla thanks his scientists for their ong...
Nov 09, 2020•38 min
Legendary investor Leon Cooperman explains his approach to markets amid the ongoing Presidential vote and the Federal Reserve’s approach to stabilizing the economy. The billionaire explains his personal vote for former Vice President Biden and his bet on equities. Uber CEO Dara Khosrowshahi unpacks his company’s latest financial results and his projection for a transportation recovery post-pandemic. In the wake of California’s Proposition 22 vote preserving gig workers’ status as contractors, Kh...
Nov 06, 2020•37 min
As 2020 election results trickle in, Al Gore’s running mate former Senator Joe Lieberman reflects on the 34 controversial days between Election Day in 2000 and Gore’s final concession. His lessons from that infamous election twenty years ago: at some point, for the good of the country, a peaceful transfer of power must ensue. Pollster and political strategist Frank Luntz considers what’s next for the candidates, the country, and his own polling profession. Whatever the outcome, Luntz says it’s o...
Nov 05, 2020•36 min
As votes are counted across the country, David Rubenstein, co-founder and co-executive chairman of The Carlyle Group, expects market jitters to continue until a clear winner emerges. He and IAC Chairman Barry Diller consider what political division in the U.S. means for the next four years of policy, business, international relations, and the American psyche, regardless of the election outcome. Diller reflects on liberal moral superiority, a potentially fatal flaw of the Democratic Party, and sa...
Nov 04, 2020•31 min
Election Day 2020 is finally here. At this culmination of America’s anxieties, former Facebook Chief Security Officer Alex Stamos discusses social media’s strategies and obligations to curb misinformation ahead of the final results. In a podcast original interview, The Wall Street Journal’s Joanna Stern shares how she found her anxiety fix in a social media blackout. Plus, regardless of the election outcome, Dr. Scott Gottlieb maps out a bumpy pandemic road ahead, and Joe, Becky, and Andrew cons...
Nov 03, 2020•35 min
Dr. Atul Gawande, Chairman of Haven, surgeon, and staff writer for The New Yorker, shares his expectations for coronavirus vaccine supply and American confidence in preventative drugs. CNBC’s Steve Liesman breaks down results from a CNBC All America Survey, revealing American faith in health care companies and the demographic disparities between those who are wary of and confident in a potential vaccine. Insider’s Henry Blodget unpacks the whirlwind week for tech and suggests that despite some d...
Oct 30, 2020•33 min
Ken Frazier, CEO of drug maker Merck, maps out his timeline for a coronavirus vaccine as cases continue to rise around the world. In a conversation with Yale School of Management’s Jeff Sonnenfeld, Frazier discusses the duty CEOs have to encourage voting, civility, and faith in the democratic process. Politics took precedence at big tech’s big (virtual) day on Capitol Hill. Former White House Chief Technology Officer Aneesh Chopra and CNBC’s Ylan Mui break down Jack Dorsey’s, Mark Zuckerberg’s, ...
Oct 29, 2020•31 min
Robinhood, the trading app that took young people and financiers by storm, now boasts 13 million user accounts. Its zero-commission trading model prompted an overhaul of the online brokerage ecosystem, although the company has run into SEC investigations, hackers, and performance outages along the way. In an extended interview with Andrew Ross Sorkin, CEO Vlad Tenev discusses the role Robinhood plays in the financial system and the risks and rewards of retail investors engaging in high volume tr...
Oct 28, 2020•29 min
The National Institutes of Health has halted one of Eli Lilly’s coronavirus antibody trials, having found that the combination of Lilly’s antibody drug and Gilead’s remdesivir does not result in a marked improvement in hospitalized Covid-19 patients. Eli Lilly CEO David Ricks discusses what’s next for the antibody that’s proven successful in treating milder Covid cases, and he addresses the company’s third quarter financials. CNBC’s All America Survey reveals that while Joe Biden is leading Pres...
Oct 27, 2020•29 min
Coronavirus cases are on the rise in Europe and in the United States, and former FDA Commissioner Dr. Scott Gottlieb says things stateside are likely to get worse before they get better. Big tech is gearing up for a big week; major players are expected to report quarterly earnings, and the CEOs of Alphabet, Facebook, and Twitter are slated to testify before the Senate Commerce Committee to discuss their content liability shield known as Section 230. Ellie Wheeler, partner at the venture capital ...
Oct 26, 2020•28 min
Pollster and political strategist Frank Luntz breaks down the last Presidential debate before Election Day. Luntz emphasizes the volume of mail in ballots expected this cycle, and projects that we won’t have a final vote count for days after November 3rd. Plus, Facebook’s former Chief Privacy Officer and General Counsel Chris Kelly discusses the challenges ahead for big tech players and the regulators who want to rein them in. Kelly considers the implications of replacing Section 230 and the rol...
Oct 23, 2020•29 min
Paul Tudor Jones, billionaire hedge fund manager and philanthropist, discusses today’s market, 33 years after Wall Street’s Black Monday. Jones considers the U.S. economic environment after the election, the value of bitcoin, market volatility, and Joe Biden’s tax plan. The Washington Football Team plays the Dallas Cowboys this Sunday, in a game dubbed “DMVotes Game,” part of Washington’s campaign to register DC, Maryland, and Virginia voters and to support them when casting their ballots. Washi...
Oct 22, 2020•36 min
Amazon is rolling out grocery pickup at Whole Foods, but Bezos may still have a few kinks to iron out to make the effort a success. Netflix reported disappointing results for its third quarter after missing subscriber targets, but Snapchat surprised the Street with a strong delivery for its investors and its advertisers. Lightshed’s Rich Greenfield and CNBC’s Julia Boorstin discuss the two platforms, and what’s to come for each. Stimulus negotiations continue on the Hill, and CNBC’s Ylan Mui tra...
Oct 21, 2020•29 min
Rapper, actor, and activist Michael Render, AKA Killer Mike, has launched Greenwood, a digital banking platform aimed at supporting Black and Latinx Americans who are unbanked or underserved by the traditional banking system in the U.S. He explains why support from financial institutions is critical to Black and brown America building wealth and participating fully in the economy. John Hope Bryant, CEO of Operation Hope, has launched the 1MBB initiative, an effort to create 1 million new Black-o...
Oct 20, 2020•33 min
Former FDA Commissioner Dr. Scott Gottlieb looks ahead to 2021 for vaccines and a possible end to the coronavirus pandemic. He says we’re nearly through, but the hardest road is still ahead. AMC movie theaters are starting to reopen in New York, and CEO Adam Aron is optimistic about cinema safety but concerned about consumer demand. He emphasizes that movie releases, not limited theater capacity, may hinder his business. Plus, stimulus negotiations slog on in Washington, and Boeing’s 737 Max is ...
Oct 19, 2020•32 min
Description: LinkedIn co-founder and “Masters of Scale” podcast host Reid Hoffman has joined a number of prominent business leaders in speaking out on election integrity. The entrepreneur, venture capitalist, and author is calling for patience and civility in awaiting election results, and considers the best options for American stability moving forward. GOP pollster Frank Luntz says undecided voters are struggling with their dislike of President Trump and their concern about Joe Biden’s policie...
Oct 16, 2020•33 min
Four months after the 200 American CEOs in the Business Roundtable committed to combating racial injustice in this country, the group has released a set of policy recommendations to hold themselves accountable to their goals, and to encourage other business leaders to do the same. Walmart CEO and BRT Chairman Doug McMillon discusses strategies for keeping the spotlight on racial inequality amid the current news cycle. McMillon underscores the real economy’s need for stimulus, his expectations fo...
Oct 15, 2020•32 min
Business magnate and philanthropist Bill Gates sits down (virtually) with Becky Quick for an extended interview. Gates discusses the U.S. response to the coronavirus pandemic, explains the Gates Foundation’s partnership with Eli Lilly to find a vaccine, and addresses Covid conspiracy theories. Amid mounting regulatory pressure on big tech, Gates, co-founder of Microsoft, reflects on his own time leading a tech giant and coming under scrutiny in Washington. Hosted by Simplecast, an AdsWizz compan...
Oct 14, 2020•25 min
Larry Fink, co-founder, Chairman, and CEO of BlackRock, gives his outlook for the markets, the U.S. economic recovery, and fiscal stimulus. For the second time, BlackRock, the world’s largest money manager, is working with the Federal Reserve to help prop up the American economy. Larry Fink considers the promise of SPACs and retail investing platforms like Robinhood, and he underscores the role corporations can play in curbing climate change. Plus, Johnson & Johnson’s Covid vaccine study is ...
Oct 13, 2020•34 min
As Covid-19 cases continue to rise in the U.S. Dr. Scott Gottlieb discusses drug treatment distribution and potential supply issues. The New York Times columnist and Pulitzer Prize winning journalist Thomas Friedman weighs the biggest issues for voters just three weeks before the Presidential election, and considers innovation in a post-pandemic world, from social media in Silicon Valley to the world’s best assistant in your pocket--and all the big tech in between. Plus, sports are finally back,...
Oct 12, 2020•38 min
